Hypoallergenic and Physicochemical Properties of the A2 β-Casein Fraction of Goat Milk

Tae-Hwan Jung,Hyo-Jeong Hwang,Sung-Seob Yun,Won-Jae Lee,Jin-Wook Kim,Ji-Yun Ahn,Woo-Min Jeon,Kyoung-Sik Han2.6* 한국축산식품학회 2017 한국축산식품학회지 Vol.37 No.6

Goat milk has a protein composition similar to that of breast milk and contains abundant nutrients, but its use in functional foods is rather limited in comparison to milk from other sources. The aim of this study was to prepare a goat A2 β-casein fraction with improved digestibility and hypoallergenic properties. We investigated the optimal conditions for the separation of A2 β-casein fraction from goat milk by pH adjustment to pH 4.4 and treating the casein suspension with calcium chloride (0.05 M for 1 h at 25°C). Selective reduction of β- lactoglobulin and αs-casein was confirmed using sodium dodecyl sulphate-polyacrylamide gel electrophoresis and reverse-phase high-performance liquid chromatography. The hypoallergenic property of A2 β-casein fraction was examined by measuring the release of histamine and tumor necrosis factor alpha from HMC-1 human mast cells exposed to different proteins, including A2 β-casein fraction. There was no significant difference in levels of both indicators between A2 β-casein treatment and the control (no protein treatment). The A2 β-casein fraction is abundant in essential amino acids, especially, branched-chain amino acids (leucine, valine, and isoleucine). The physicochemical properties of A2 β-casein fraction, including protein solubility and viscosity, are similar to those of bovine whole casein which is widely used as a protein source in various foods. Therefore, the goat A2 β-casein fraction may be useful as a food material with good digestibility and hypoallergenic properties for infants, the elderly, and people with metabolic disorders.

Analysis of the Relationships according to the Frame (f/s) Change of Cine Imaging in Coronary Angiographic System: With Focus on FOV Enlargement and Live Zoom

Won Hyo Kim,Jong-Nam Song,Jae-Bok Han 한국방사선학회 2018 한국방사선학회 논문지 Vol.12 No.7

본 연구는 심장 혈관 조영술의 투시 영상과 씨네 영상을 획득하는 데 있어서 초당 프레임 횟수를 변화함에 따라 흡수선량과 획득 영상의 화질의 추이를 살펴보는 것을 목적으로 한다. 또, FOV 확대와 Live Zoom이라는 두 가지 확대 모드에 따른 변화도 고찰 대상으로 한다. 인체모형 팬텀을 심장 혈관 조영장치 위에서 초당 프레임 횟수를 7.5, 15, 30 f/s로 설정하고 두 가지 확대 모드에 대하여 각각 5회씩 촬영하였다. 선량의 척도로서는 흡수선량과 에어 커머가 사용되었고, 화질 평가의 척도로는 잡음의 세기로서의 표준 편차(SD), 신호 대 잡음비(SNR)와 대조도 대 잡음비(CNR) 등을 활용하였다. 초당 프레임 횟수가 30부터 15, 7.5 f/s로 감소되었을 때, DAP와 에어 커머는 동일한 비율로 감소하였으나, 화질의 척도인 SD, SNR과 CNR은 거의 변화가 없었다. 확대 모드에의 의존도에 관해서는, Live Zoom이 FOV 확대와 비교하였을 때, DAP, 에어 커머와 SD에 대해서는 통계적 의미 있는 차이를 보이지 않았으나, SNR과 CNR에 있어서는 통계적 유의미한 개선을 보였다. 이러한 실험 결과에 의하여, 초당 프레임 횟수는 화질의 열화 없이 되도록 낮게 설정하는 것이 가능하며, 확대 모드도 추가적인 선량 없이 실시간 확대가 가능한 Live Zoom 모드를 적극적으로 활용 가능하며 이는 화질의 여러 척도의 저하를 가져오지 않음을 알 수 있었다. This study aimed to investigate the difference of X-ray exposure by comparing and analyzing absorbed dose according to changes in the number of frames in coronary angiography, also depending whether the zoom mode is FOV enlargement or Zoom Live. Moreover, for appropriate frame selection measures for examination, including the effect of frame change on the image quality, were sought by measuring the noise strength expressed by the standard deviation (SD), the signal to noise ratio (SNR) and contrast to noise ratio (CNR). The study was conducted with an anthropomorphic phantom on an angio-system. The linear relationship between the frame rate and the radiation dose was evident. On the contrary, the indices of image quality (SD, SNR, and CNR) were almost constant irrespective of the number of frames. The difference depending on the zoom mode was not statistically significant for DAP, air kerma, and SD (p > 0.05). However, SNR and CNR were statistically different between FOV enlargement and Zoom Live. In conclusion, since the image quality was not degraded significantly with the decreasing frame rate from 30, 15, to 7.5 f/s and the radiation dose evidently decreases in almost exactly linear proportion to the decreasing frame rate, the number of frames per second needs to be maintained as low as reasonably achievable. As for the dependence on the zooming mode, the Live Zoom mode showed statistically significant improvement in the image quality indices of SNR and CNR and it justifies active use of the Live Zoom mode which enables real-time image enlargment without additional radiation dose.

Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome

Hyo Jeong Lee,Hyun Jin Kim,Eun Hee Kang,Kee Wook Jung,Seung-Jae Myung,Yang Won Min,Chang Hwan Choi,Han Seung Ryu,Jong Kyoung Choi,Joong Goo Kwon,Kyoung Sup Hong,Kyung Sik Park 대한소화기 기능성질환∙운동학회 2019 Journal of Neurogastroenterology and Motility (JNM Vol.25 No.2

Background/Aims Various foods trigger and/or worsen the symptoms of irritable bowel syndrome (IBS). However, Korean food-related gastrointestinal (GI) symptoms in IBS patients have not yet been investigated. This study aims to evaluate the prevalence of self-reported food intolerance in Korean IBS patients and determine the Korean food items and food groups perceived by patients to worsen their GI symptoms. Methods We recruited 393 study subjects, comprising 101 IBS patients, 167 symptomatic non-IBS subjects, and 125 control subjects. All participants completed a questionnaire to identify the most problematic foods and assess the occurrence of GI symptoms caused by 119 Korean food items. They also completed the validated Rome III questionnaire for IBS. Results The prevalence of self-reported food intolerance in Korean IBS patients was 79.2%, which was significantly higher than that in control subjects (44.8%, P < 0.001). The most problematic foods reported by IBS patients who experienced food intolerance were high-fat foods (25.0%), gluten foods (23.8%), spicy foods (15.0%), and dairy products (15.0%). A total of 63.4% of IBS patients reported GI symptoms related to the consumption of foods high in fermentable oligo-, di-, mono-saccharides, and polyols (FODMAP), while 48.5% of IBS patients reported symptoms associated with high-fat foods. Gas problems and loose stools were the most frequently reported symptoms. Conclusions A large proportion of Korean IBS patients complained of intolerance to certain food items, with high-fat and high-FODMAP foods being the main triggers. This study provides a basis for planning food intervention studies for Korean IBS patients. Background/Aims Various foods trigger and/or worsen the symptoms of irritable bowel syndrome (IBS). However, Korean food-related gastrointestinal (GI) symptoms in IBS patients have not yet been investigated. This study aims to evaluate the prevalence of self-reported food intolerance in Korean IBS patients and determine the Korean food items and food groups perceived by patients to worsen their GI symptoms. Methods We recruited 393 study subjects, comprising 101 IBS patients, 167 symptomatic non-IBS subjects, and 125 control subjects. All participants completed a questionnaire to identify the most problematic foods and assess the occurrence of GI symptoms caused by 119 Korean food items. They also completed the validated Rome III questionnaire for IBS. Results The prevalence of self-reported food intolerance in Korean IBS patients was 79.2%, which was significantly higher than that in control subjects (44.8%, P < 0.001). The most problematic foods reported by IBS patients who experienced food intolerance were high-fat foods (25.0%), gluten foods (23.8%), spicy foods (15.0%), and dairy products (15.0%). A total of 63.4% of IBS patients reported GI symptoms related to the consumption of foods high in fermentable oligo-, di-, mono-saccharides, and polyols (FODMAP), while 48.5% of IBS patients reported symptoms associated with high-fat foods. Gas problems and loose stools were the most frequently reported symptoms. Conclusions A large proportion of Korean IBS patients complained of intolerance to certain food items, with high-fat and high-FODMAP foods being the main triggers. This study provides a basis for planning food intervention studies for Korean IBS patients.

Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer

Han, Myung Woul,Ryu, In Sun,Lee, Jong Cheol,Kim, Song Hee,Chang, Hyo Won,Lee, Yoon Sun,Lee, Seulkina,Kim, Seong Who,Kim, Sang Yoon Elsevier 2018 Oral oncology Vol.78 No.-

<P><B>Abstract</B></P> <P> <I>Objectives</I>: PI3K/Akt/mTOR pathway is commonly activated in most cancers and is correlated with resistance to anticancer therapies such as radiotherapy. Therefore, PI3K is an attractive target for treating PI3K-associated cancers. <I>Material and Methods</I>: We investigated the basal expression and the expression after treatment of PI3K inhibitor or Src inhibitor of PI3K/Akt pathway-related proteins in AMC-HN3, AMC-HN3R, HN30 and HN31 cells by performing immunoblotting analysis. The sensitivity to PI3K inhibitors or Src inhibitor was analyzed by MTT assay and clonogenic assay. To determine the antitumoral activity of combination treatment with PI3K inhibitor and Src inhibitor, we used using xenograft mouse model. <I>Results</I>: We found that PI3K regulatory subunit p85 was predominantly phosphorylated in radioresistant head and neck cancer cell line (HN31), which showed resistance to PI3K inhibitors. Next, we investigated mechanism through which PI3K p85 phosphorylation modulated response to PI3K inhibitors. Of note, constitutive activation of Src was found in HN31 cells and upon PI3K inhibitor treatment, restoration of p-Src was occurred. Src inhibitor improved the efficacy of PI3K inhibitor treatment and suppressed the reactivation of both Src and PI3K p85 in HN31 cells. Furthermore, downregulation of PI3K p85 expression by using a specific siRNA suppressed Src phosphorylation. <I>Conclusions</I>: Together, our results imply the novel role of the PI3K regulatory subunit p85 in the development of resistance to PI3K inhibitors and suggest the presence of a regulatory loop between PI3K p85 and Src in radioresistant head and neck cancers with constitutively active PI3K/Akt pathway.</P> <P><B>Highlights</B></P> <P> <UL> <LI> PI3K p85 was predominantly phosphorylated in radioresistant HN cancer cell (HN31). </LI> <LI> Sustained p85 and Src phosphorylation mediated resistance to PI3K inhibitors. </LI> <LI> Src inhibitor improved the efficacy of PI3K inhibitor treatment in HN31 cell line. </LI> <LI> Combination of Src and PI3K inhibitors suppressed the activation of Src and p85. </LI> </UL> </P>

Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping

Han, Sang Won,Kim, Yong-Jae,Ahn, Seong Hwan,Seo, Woo-Keun,Yu, Sungwook,Oh, Seung-Hun,Nam, Hyo Suk,Choi, Hye-Yeon,Yoon, Sung Sang,Kim, Seo Hyun,Lee, Jong Yun,Lee, Jun Hong,Hwang, Yang-Ha,Lee, Kee Ook,J Korean Stroke Society 2017 Journal of stroke Vol.19 No.3

<P><B>Background and Purpose</B></P><P> To compare the efficacy and safety of antiplatelet agents for the secondary prevention of ischemic stroke based on cytochrome P450 2C19 (CYP2C19) polymorphisms. </P><P><B>Methods</B></P><P> This study was a prospective, multicenter, randomized, parallel-group, open-label, blind genotype trial. First time non-cardiogenic ischemic stroke patients were enrolled and screened within 30 days. Participants were randomized to receive either triflusal or clopidogrel for secondary stroke prevention. The primary outcome was the time from randomization to first recurrent ischemic stroke or hemorrhagic stroke. </P><P><B>Results</B></P><P> The required sample size was 1,080 but only 784 (73%) participants were recruited. In patients with a poor CYP2C19 genotype for clopidogrel metabolism (n=484), the risk of recurrent stroke among those who received triflusal treatment was 2.9% per year, which was not significantly different from those who received clopidogrel treatment (2.2% per year; hazard ratio [HR], 1.23; 95% confidence interval [CI], 0.60–2.53). In the clopidogrel treatment group (n=393), 38% had good genotypes and 62% poor genotypes for clopidogrel metabolism. The risk of recurrent stroke in patients with a good CYP2C19 genotype was 1.6% per year, which was not significantly different from those with a poor genotype (2.2% per year; HR, 0.69; 95% CI, 0.26–1.79). </P><P><B>Conclusions</B></P><P> Whilst there were no significant differences between the treatment groups in the rates of stroke recurrence, major vascular events, or coronary revascularization, the efficacy of antiplatelet agents for the secondary prevention of stroke according to CYP2C19 genotype status remains unclear.</P>

Estimating Chemical Value of Forage from Grazing Area Using Near-infrared Spectroscopy with Different Wavelength Based on Partial Least Squares Regression

Hyo-Won Lee,Hyung-soo Park,Hyo-Jin Lee,Han-Jong Ko 한국초지조사료학회 2016 한국초지조사료학회 학술대회논문집 Vol.2016 No.08

Control Efficacy and Phytotoxiciy of Potassium Phosphonate Solution against Powdery Mildew on Watermelon in Green House Cultivation

Hyo Jung Kang,Sang Hee Kim,Bong Tae Han,Tae Il Kim,Sang Young Lee,Sang Cheol Lim,Jong Won Lee 한국원예학회 2010 한국원예학회 학술발표요지 Vol.2010 No.10

Adaptive windowing for gait phase discrimination in Parkinsonian gait using 3-axis acceleration signals

Han, Jonghee,Jeon, Hyo Seon,Yi, Won Jin,Jeon, Beom Seok,Park, Kwang Suk Springer-Verlag 2009 Medical & biological engineering & computing Vol.47 No.11

Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects

( Hyo Jeong Lee ),( Yeongyu Moon ),( Jungil Choi ),( Jeong Doo Heo ),( Sekwang Kim ),( Hari Krishna Nallapaneni ),( Young-won Chin ),( Jongkook Lee ),( Sun-young Han ) 한국응용약물학회 2022 Biomolecules & Therapeutics(구 응용약물학회지) Vol.30 No.4

Tropomyosin receptor kinase A (TrkA) protein is a receptor tyrosine kinase encoded by the NTRK1 gene. TrkA signaling mediates the proliferation, differentiation, and survival of neurons and other cells following stimulation by its ligand, the nerve growth factor. Chromosomal rearrangements of the NTRK1 gene result in the generation of TrkA fusion protein, which is known to cause deregulation of TrkA signaling. Targeting TrkA activity represents a promising strategy for the treatment of cancers that harbor the TrkA fusion protein. In this study, we evaluated the TrkA-inhibitory activity of the benzoxazole compound KRC-108. KRC-108 inhibited TrkA activity in an in vitro kinase assay, and suppressed the growth of KM12C colon cancer cells harboring an NTRK1 gene fusion. KRC-108 treatment induced cell cycle arrest, apoptotic cell death, and autophagy. KRC-108 suppressed the phosphorylation of downstream signaling molecules of TrkA, including Akt, phospholipase Cγ, and ERK1/2. Furthermore, KRC-108 exhibited antitumor activity in vivo in a KM12C cell xenograft model. These results indicate that KRC-108 may be a promising therapeutic agent for Trk fusion-positive cancers.

Phylogenetic analysis and molecular identification of skin flukes isolated from small yellow croaker(Larimichthys polyactis)

Han-Gill Seo,Hyo-Won Kim,Jung-Hyun Kim 한국수산과학회 양식분과 2022 한국수산과학회 양식분과 학술대회 Vol.2022 No.5